Skip to content
Wednesday, October 28, 2026 · Today’s edition, 6:30 a.m. ETWed, Oct 28 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
PSILAdvisorSharesACTIVE

AdvisorShares Psychedelics ETF

$21.45+2.05% vs prior close
15.632752-WK

Price through Oct 28, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Oct 28, 2026. Holdings snapshot retrieved Oct 28, 2026.

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

PSIL price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DatePSIL close
Sep 28, 2026$23.14
Sep 29, 2026$22.90
Sep 30, 2026$22.50
Oct 1, 2026$22.06
Oct 2, 2026$21.85
Oct 5, 2026$21.61
Oct 6, 2026$21.24
Oct 7, 2026$21.16
Oct 8, 2026$20.99
Oct 9, 2026$21.77
Oct 12, 2026$21.25
Oct 13, 2026$20.29
Oct 14, 2026$20.09
Oct 15, 2026$20.54
Oct 16, 2026$19.90
Oct 19, 2026$20.17
Oct 20, 2026$21.08
Oct 21, 2026$21.02
Oct 22, 2026$20.93
Oct 23, 2026$20.64
Oct 26, 2026$20.67
Oct 27, 2026$21.02
Oct 28, 2026$21.45

The desk’s read

Recent fund-flow records are unavailable, while the price has returned +24.9% so far this year. At 0.99% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$5Massets under management
0.99%expense ratio · $99 per $10,000 a year
—net flow, trailing month
22Kavg daily volume, 30 days
26holdings
2021listed September 16, 2021 · beta 1.14

Sector weights

  • Healthcare100%
  • Health Technology95.32%
  • Health Services3.77%
  • Other1.61%
  • Mutual fund0.91%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Healthcare100%
Health Technology95.32%
Health Services3.77%
Other1.61%
Mutual fund0.91%

Country weights

  • United States54.05%
  • Canada22.65%
  • Other9.58%
  • United Kingdom8.45%
  • Germany5.22%
  • Australia4.92%
  • Ireland4.7%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States54.05%
Canada22.65%
Other9.58%
United Kingdom8.45%
Germany5.22%
Australia4.92%
Ireland4.7%
Performance
1 week+2.5%
1 month-7.3%
3 months-7.3%
6 months+7.3%
YTD+24.9%
1 year+5.9%
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week—
1 month—
3 months—
YTD—
1 year—

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

The risk read
34%realized volatility, 30 days (annualized)
39%realized volatility, 1 year
-25.7%deepest fall from a peak, 1 year
-20.0%latest close versus that peak

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
2calls · latest snapshot
1puts · latest snapshot
0.50put/call ratio
5Kshares traded
The case against PSIL

Due diligence cuts both ways. These funds sit on the same shelf and beat PSIL on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
SPDW SPDR Portfolio Developed World ex-US ETF0.03%$40.7B+$609M-96bp on fee · 7934× the assets · +$609M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.4B+$199M-96bp on fee · 3575× the assets · +$199M in over the monthHead-to-head
IDEV iShares Core MSCI International Developed Markets ETF0.04%$32.4B+$497M-95bp on fee · 6314× the assets · +$497M in over the monthHead-to-head
IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF0.04%$23.7B+$47M-95bp on fee · 4620× the assets · +$47M in over the monthHead-to-head
IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF0.04%$18.6B+$412M-95bp on fee · 3621× the assets · +$412M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.